Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
Bangladesh · Delayed Price · Currency is BDT 108.20
-1.50 (-1.37%)
At close: Jul 23, 2026
Beacon Pharmaceuticals Market Cap
Beacon Pharmaceuticals has a market cap or net worth of 24.83 billion as of July 24, 2026. Its market cap has decreased by -8.04% in one year.
Market Cap
24.83B
Enterprise Value
33.87B
Revenue
15.57B
Ranking
n/a
PE Ratio
17.04
Stock Price
108.20
ChartMarket Cap Chart
Since August 12, 2010, Beacon Pharmaceuticals's market cap has increased from 19.93B to 24.83B, an increase of 24.59%. That is a compound annual growth rate of 1.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 24.99B | 3.44% |
| Dec 30, 2025 | 24.16B | -23.03% |
| Dec 30, 2024 | 31.39B | -44.53% |
| Dec 28, 2023 | 56.60B | -14.34% |
| Dec 29, 2022 | 66.07B | 17.50% |
| Dec 30, 2021 | 56.23B | 210.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 195.29B |
| Beximco Pharmaceuticals PLC. | 66.07B |
| Renata | 54.38B |
| Unilever Consumer Care | 39.67B |
| The ACME Laboratories | 17.52B |
| Asiatic Laboratories | 15.14B |
| The IBN SINA Pharmaceutical Industry | 10.05B |
| Navana Pharmaceuticals | 7.65B |